163 related articles for article (PubMed ID: 24530416)
1. Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice.
Novelli M; Canistro D; Martano M; Funel N; Sapone A; Melega S; Masini M; De Tata V; Pippa A; Vecoli C; Campani D; De Siena R; Soleti A; Paolini M; Masiello P
Eur J Pharmacol; 2014 Apr; 729():37-44. PubMed ID: 24530416
[TBL] [Abstract][Full Text] [Related]
2. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
3. Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger.
Novelli M; Bonamassa B; Masini M; Funel N; Canistro D; De Tata V; Martano M; Soleti A; Campani D; Paolini M; Masiello P
Naunyn Schmiedebergs Arch Pharmacol; 2010 Aug; 382(2):127-37. PubMed ID: 20512314
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone, a PPAR-gamma ligand inhibited the nicotinamide-streptozotocin induced sperm abnormalities in type-2 diabetic Wistar rats.
Rabbani SI; Devi K; Khanam S
Pak J Pharm Sci; 2010 Jul; 23(3):326-31. PubMed ID: 20566448
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a new delivery system based on solid lipid microparticles for the oral administration of the non-conventional antioxidant IAC on a diabetes mouse model.
Canistro D; Vivarelli F; Cirillo S; Soleti A; Albertini B; Passerini N; Merizzi G; Paolini M
J Endocrinol Invest; 2018 Oct; 41(10):1227-1236. PubMed ID: 29511967
[TBL] [Abstract][Full Text] [Related]
6. Exendin-4 improves hepatocyte injury by decreasing proliferation through blocking NGF/TrkA in diabetic mice.
Gezginci-Oktayoglu S; Sacan O; Yanardag R; Karatug A; Bolkent S
Peptides; 2011 Feb; 32(2):223-31. PubMed ID: 21055431
[TBL] [Abstract][Full Text] [Related]
7. Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.
Ozyazgan S; Kutluata N; Afşar S; Ozdaş SB; Akkan AG
Pharmacology; 2005 Jun; 74(3):119-26. PubMed ID: 15746570
[TBL] [Abstract][Full Text] [Related]
8. Anti-diabetic effects of electrolyzed reduced water in streptozotocin-induced and genetic diabetic mice.
Kim MJ; Kim HK
Life Sci; 2006 Nov; 79(24):2288-92. PubMed ID: 16945392
[TBL] [Abstract][Full Text] [Related]
9. Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area.
Xue S; Wasserfall C; Parker M; McGrail S; McGrail K; Campbell-Thompson M; Schatz DA; Atkinson MA; Haller MJ
J Diabetes Complications; 2010; 24(3):163-7. PubMed ID: 19217320
[TBL] [Abstract][Full Text] [Related]
10. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction contribute to diabetic neurotoxicity induced by streptozocin in mice: protective effect of Urtica dioica and pioglitazone.
Shokrzadeh M; Mirshafa A; Yekta Moghaddam N; Birjandian B; Shaki F
Toxicol Mech Methods; 2018 Sep; 28(7):499-506. PubMed ID: 29606029
[TBL] [Abstract][Full Text] [Related]
12. Exendin-4 treatment expands graft beta-cell mass in diabetic mice transplanted with a marginal number of fresh islets.
Juang JH; Kuo CH; Wu CH; Juang C
Cell Transplant; 2008; 17(6):641-7. PubMed ID: 18819252
[TBL] [Abstract][Full Text] [Related]
13. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice.
Fukudome D; Matsuda M; Kawasaki T; Ago Y; Matsuda T
Eur J Pharmacol; 2008 Mar; 583(1):164-9. PubMed ID: 18291360
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes.
Diani AR; Sawada G; Wyse B; Murray FT; Khan M
Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E116-22. PubMed ID: 14532171
[TBL] [Abstract][Full Text] [Related]
15. Exendin-4 protects hypoxic islets from oxidative stress and improves islet transplantation outcome.
Padmasekar M; Lingwal N; Samikannu B; Chen C; Sauer H; Linn T
Endocrinology; 2013 Apr; 154(4):1424-33. PubMed ID: 23471218
[TBL] [Abstract][Full Text] [Related]
16. The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats.
Kaya-Dagistanli F; Ozturk M
Acta Histochem; 2013 Jul; 115(6):577-86. PubMed ID: 23351716
[TBL] [Abstract][Full Text] [Related]
17. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats.
Chaudhry J; Ghosh NN; Roy K; Chandra R
Life Sci; 2007 Feb; 80(12):1135-42. PubMed ID: 17234217
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.
Shen X; Li H; Li W; Wu X; Ding X
Mol Cell Endocrinol; 2012 Nov; 363(1-2):27-35. PubMed ID: 22820128
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: Possible protection of beta cells from oxidative stress.
Ishida H; Takizawa M; Ozawa S; Nakamichi Y; Yamaguchi S; Katsuta H; Tanaka T; Maruyama M; Katahira H; Yoshimoto K; Itagaki E; Nagamatsu S
Metabolism; 2004 Apr; 53(4):488-94. PubMed ID: 15045697
[TBL] [Abstract][Full Text] [Related]
20. Mogrosides extract from Siraitia grosvenori scavenges free radicals in vitro and lowers oxidative stress, serum glucose, and lipid levels in alloxan-induced diabetic mice.
Qi XY; Chen WJ; Zhang LQ; Xie BJ
Nutr Res; 2008 Apr; 28(4):278-84. PubMed ID: 19083420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
